The US Food and Drug Administration has approved Vyloy (zolbetuximab-clzb), a claudin 18.2 (CLDN18.2)-directed cytolytic ...

As the European Parliament prepares for the confirmation hearings of the new Commissioners, the Open Trade Coalition is ...

A century later, that sentiment is as pertinent as ever. Artificial Intelligence (AI) is being incorporated into a myriad of ...

After a couple of negative decisions, the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and ...

Shanghai-based biopharma LaNova Medicines has raised 3 billion yuan ($41 million) in a series C round led by China ...

OmniaBio, a subsidiary of Canada's Centre for Commercialization of Regenerative Medicine, has opened a 120,000-square-foot ...

Taiwan-based REGiMMUNE, a biopharma creating immunotherapies through the power of regulatory T cells (Tregs), and ...

Texas, USA-based Lexicon Pharmaceuticals announced that Viatris has obtained an exclusive license from Lexicon to ...

British AI drug discovery firm BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. His ...

The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...

A new NIH clinical trial shows the Jynneos (MVA-BN) vaccine is safe for adolescents and produces an antibody response similar ...

Gan & Lee Pharmaceuticals (SHE: 603087) reported positive Phase II trial results for its diabetes drugs GZR18, GZR4, and ...